“alzheimers”的搜索结果，显示 11-20 项，共有 8725 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.

2. 神经科- 临床试验- 妙佑医疗国际

   There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013).

3. 精神病与心理科- 临床试验- 妙佑医疗国际

   There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013).

4. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.

5. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.

6. 阿尔茨海默病：药物有助于控制症状和延缓衰退

   AskMayoExpert. Alzheimer disease dementia. Mayo Clinic; 2023. What is mild cognitive impairment? National Institute on Aging. https://www.nia.nih.gov/health/ ...

7. 神经科- 临床试验- 妙佑医疗国际

   There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013).

8. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.

9. 路易体痴呆症：研究 - 妙佑医疗国际

   妙佑医疗国际神经科医生、医学博士Dennis W. Dickson 和心理医生Tanis J. Ferman 博士讨论今日话题：路易体痴呆症研究。

10. 神经科- 临床试验- 妙佑医疗国际

    ... Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.